INTRODUCTION
A biosynthetic pathway for glycosylphosphatidylinositols (GPIs) in mammalian cells has been deduced from analysis of several mutant cell lines that are defective in the expression of GPIanchored proteins [1] [2] [3] [4] . The pathway involves the stepwise addition of monosaccharides to phosphatidylinositol (PI) to form glycolipids with the core glycan structure of EthN-P6Manα1-2Manα1-6Manα1-4GlcN attached to an inositol phospholipid (Scheme 1 ; reviewed in [5] [6] [7] [8] ). The affected cells of patients with paroxysmal nocturnal haemoglobinuria (PNH) acquire a somatic mutation in the first step of GPI biosynthesis, the transfer of GlcNAc from UDP-GlcNAc to PI. This mutation is equivalent to complementation class A derived previously in murine lymphoma cell lines [9] [10] [11] [12] . PNH cells are susceptible to autologous complement-mediated lysis since DAF (decayaccelerating factor) and CD59, the GPI-anchored proteins responsible for preventing this autolysis, are not expressed on the cell surface [13] . Although the class A cDNA (PIG-A) responsible for this mutation has been cloned, gene therapy for treatment of PNH requires further development. A possible alternative therapeutic approach is to provide PNH cells with an exogenous lipid corresponding to a GPI intermediate downstream from the block in PNH. The structure of such a lipid would have to include a GlcN in an α-1,6 linkage to inositol (Scheme 1).
To explore the ability of cells to take up and metabolize exogenous inositol phospholipids, we first studied exogenous sn-1-acyl-2-lyso-PI (lyso-PI) and PI [14] . We selected a HeLa S3 subline (subline D) as an attractive experimental system because these cells accumulate GlcN(acyl)PI [glucosaminyl(acyl)PI, which is glucosaminyl-PI (GlcN-PI) with a fatty acid acyl group on the inositol], the fourth intermediate in the proposed GPI biosynthetic pathway (Scheme 1), during metabolic labelling with [$H]inositol [15] . We found that both lyso-[$H]PI and [$H]PI were substantially taken up by HeLa D cells [14] . lyso-[$H]PI showed a greater extent of uptake and substantial cellular sn-2 acylation to [$H]PI. Furthermore, the incorporated lyso-[$H]PI and [$H]PI were translocated inside the cell and effectively modified into and accumulated as GlcN(acyl)[$H]PI, indicating that an exogenous lipid can proceed at least midway through the GPI pathway.
To continue our studies we then asked whether an exogenous lipid corresponding to an early intermediate in the GPI biosynthetic pathway could be incorporated extensively into cultured cells, and whether the incorporated lipid could be effectively metabolized through the GPI pathway bypassing the block in
Scheme 1 Proposed pathway for GPI biosynthesis in mammalian cells
Inositol is represented by a hexagon ; phosphate by P ; fatty acyl or alkyl groups by wavy lines ; Man by M ; and ethanolamine by EthN. Mutations in the PIG-A gene, indicated by an A, cause PNH. The last three structures are denoted H6, H7 and H8.
PNH. sn-1-Alkyl-sn-2-lyso-GlcN-PI (lyso-alkyl-GlcN-PI) is a logical choice for this uptake study because (i) similar to lyso-PI, it contains only one hydrophobic chain, allowing the lipid easily to diffuse as a monomer through the aqueous medium and insert into the outer leaflet of the plasma membrane, (ii) its structure is related to GlcN-PI, the third intermediate in the GPI pathway and thus downstream from the block in PNH (see Scheme 1) and (iii) it can be readily produced by alkaline hydrolysis of purified GlcN(acyl)PI. We showed that exogenous lyso-alkyl-GlcN-PI is substantially incorporated into cells and metabolized into GlcN-PI and GlcN(acyl)PI. However, further metabolism of the accumulated GlcN(acyl)PI to mannosylated GPIs could not be detected. We investigated the basis of this poor conversion by metabolic labelling with [ [16] ) were pooled and concentrated in a SpeedVac (Savant), and GlcN(acyl)PI was extracted from the pooled fraction by partitioning with n-butanol (the overall radiochemical yield was 2-3 % based on initial [$H]inositol). For base methanolysis, 1.5-2 µCi of GlcN(acyl)[$H]PI was dried and incubated with 50 µl of 0.2 M KOH in methanol for 30 min in a bath sonicator at room temperature. The reaction was stopped by adding 2 µl of glacial acetic acid, and the mixture was dried in a SpeedVac. After partitioning with n-butanol, the yield of alkalineresistant lipid (lyso-alkyl-GlcN-[$H]PI) was $ 8-20 % of the initial GlcN(acyl)[$H]PI. The purity of lyso-alkyl-GlcN-[$H]PI was determined to be at least 85-90 % by TLC, and no other discrete bands were detected. [$H]PI and lyso-[$H]PI (both at $ 1 Ci\mmol) were prepared as described previously [14] , and $Hlabelled H6, H7 and H8 lipid standards (Scheme 1) were prepared by metabolic labelling with [$H]Man [17, 18] .
Incubation of HeLa D cells with lyso-alkyl-GlcN-[ 3 H]PI
HeLa D cells [15] were maintained in 3 ml of medium 2 (DMEM, 10 % fetal bovine serum, 50 units\ml penicillin, 50 µg\ml streptomycin and 5 % CO # ) at 37 mC and replated 24 h before each experiment. For lyso-alkyl-GlcN-[$H]PI uptake, the lipid was dried, dissolved in ethanol and added to DMEM or DMEM plus 10 mM EGTA (the final concentration of ethanol was less than 1 %). Cells (5i10') on a 60 mm-diameter dish were washed twice with 3 ml of serum-free DMEM prior to addition of 3 ml of the lipid-containing medium. After incubation for 24 h in 5 % CO # at 37 mC, the cells and medium were removed and the pelleted cells were washed once with 3 ml of prechilled serumfree DMEM and incubated in 1 ml of serum-free DMEM for 1 h at 4 mC with or without 0.5 µg of purified Bacillus thuringiensis PI-specific phospholipase C (PI-PLC) [16] . The treated cells were washed twice with 3 ml of prechilled serum-free DMEM and lysed by adding 1 ml of chloroform\methanol (1 : 1, v\v) to a final mixture of chloroform\methanol\water (10 : 10 : 3, by vol.). The remaining pellet was re-extracted twice with 1 ml of chloroform\methanol\water (10 : 10 : 3, by vol.). The extract supernatants were combined, dried and partitioned by resuspending in 400 µl of water-saturated n-butanol and 200 µl of n-butanol-saturated water. The aqueous phase was removed and extracted with 200 µl of water-saturated n-butanol. The butanol phases were combined and re-extracted with fresh 200 µl of n-butanol saturated water. The aqueous phases were also combined. Both pools were dried for analysis by TLC. Except where noted, the TLC plate was developed with a neutral solvent system of chloroform\methanol\water (10 : 10 : 3 
Sequential double labelling of HeLa D cell lipids with [ 14 C]inositol and [ 3 H]inositol
HeLa D cells (1i10' cells) on a 100 mm-diameter dish were washed twice with 5 ml of inositol-free DMEM and incubated with 2 µCi of ["%C]inositol (American Radiolabelled Chemicals ; 0.3 Ci\mmol) in 8 ml of medium 1. After incubation for 60 h in 5 % CO # at 37 mC, the conditioned medium was removed and the cells were washed once with 5 ml of inositol-free DMEM. Cells were then incubated with 7 µg\ml PI-PLC in 3 ml of inositol-free DMEM in 5 % CO # at 37 mC for 1 h to remove cell-surface GPIanchored proteins and washed three times with 5 ml of inositolfree DMEM. The incubation was then continued with 50 µCi of [$H]inositol (20 Ci\mmol) in 8 ml of medium 1 for an additional 6-12 h. Cells were removed from the dish by scraping in the conditioned medium on ice, washed once with 3 ml of inositolfree DMEM and treated with 7 µg\ml PI-PLC in 1 ml of inositol-free DMEM for 1 h in 5 % CO # at 37 mC to remove GPI-anchored proteins recently transferred to the cell surface. The treated cells were washed three times with 5 ml of prechilled inositol-free DMEM, lysed by extraction with chloroform\ methanol\water (10 : 10 : 3, by vol.), and partitioned with n-butanol as described above. The n-butanol phase of the cell extract was dried and taken for TLC analysis.
The lipid extract from the labelled cells was spotted with 50 µl of water-saturated n-butanol as a 4 cm-long band on to a silica gel 60 TLC plate and developed with a solvent system of chloroform\methanol\water (10 : 10 : 3, by vol.). The mobilities of radiolabelled lipids were observed following fluorography after spraying the plate with EN$HANCE. Bands corresponding to radiolabelled lipids detected by fluorography were scraped from the TLC plate and transferred to scintillation vials containing 0.5 ml of methanol, and 5 ml of scintillation fluid cocktail (Formula 963, NEN) was added for liquid scintillation counting. Corrections were applied for 31.25 % of the "%C counts that crossed into the $H channel (none of the $H counts crossed into the "%C channel).
Incorporation of the radiolabel into GPI anchors was estimated by measuring the radioactivity of proteins released from cells by PI-PLC treatments. The medium containing PI-PLC and released GPI-anchored proteins was dried, resuspended in 100 µl of water, and mixed with 50 µl of 1 g\ml trichloroacetic acid\ 4 mg\ml deoxycholic acid. This suspension was kept at 4 mC overnight, centrifuged at 14 000 g at 4 mC for 15 min, washed twice with 500 µl of cold acetone and centrifuged again under the same conditions. The pellet was resuspended by adding 40 µl of SDS gel-loading buffer containing 50 mM dithiothreitol, heated to 65 mC for 5 min and loaded on to a SDS\polyacrylamide (10 %) gel [19] . The developed gel was fixed in 100 mg\ml acetic acid\100 mg\ml glycerol for at least 15 min, and lanes containing the labelled GPI-anchored proteins were removed from the gel and cut transversely at 5 mm intervals with a gel slicer. Each gel slice was transferred to a scintillation vial, hydrated with 0.5 ml of water, hydrolysed with 0.5 ml of Solvable4 at 50 mC for at least 3 h to release the radiolabel from the gel, neutralized with 40 µl of HCl and supplemented with 10 ml of scintillation fluid cocktail. The samples were left at room temperature for 2 days to equilibrate the released radiolabel with the cocktail prior to counting on a liquid scintillation counter. The extent of crossover between counts in the "%C and $H channels was the same as that in lipid bands scraped from TLC plates. We assessed (i) the level of exogenous lipid uptake, (ii) its extent of localization on the cell surface and (iii) its metabolism to downstream GPI intermediates. HeLa D cells were incubated with the exogenous lipid for 24 h and then washed to remove residual label in the medium. After brief treatment with PI-PLC at 4 mC to remove susceptible labelled inositol phospholipids from the cell surface, the cells were scraped from the dish and extracted for determination of cellular lipids.
RESULTS

Uptake of lyso-alkyl-GlcN-[ 3 H]PI by HeLa D cells
In initial experiments the efficiency of lyso-alkyl-GlcN-[$H]PI uptake was low, corresponding to only 23 % of the total label after a 24 h incubation, and most of this label was recovered in intracellular lipids (see Table 1 ). Degradation products obtained as hydrophilic metabolites in the medium were very abundant and constituted 67 % of the total label. We reasoned that this degradation might result from the action of extracellular Ca# + -dependent phospholipase(s), so we examined the effect of EGTA, a Ca# + -chelating agent, on the uptake of lyso-alkyl-GlcN- [ Table 1 ). The protective effect of EGTA was greater on these lyso lipids than on PI. EGTA addition did not increase [$H]PI uptake and
Table 1 Distribution of radiolabel in HeLa D cells and in medium after incubation with 0.08-0.2 µCi of exogenous tritiated lyso-alkyl-GlcN-PI, lyso-PI or PI for 24 h
Incubations were conducted with or without addition of 10 mM EGTA to the medium. Cell-surface lipid was determined as radioactive label released from washed intact cells by treatment with PI-PLC for 1 h at 4 mC. Cells were then extracted with chloroform/methanol/water (10 : 10 : 3, by vol.), and both the cell extract and medium were partitioned with n-butanol into organic (intracellular lipids) and aqueous (hydrophilic metabolites) phases as outlined in the Experimental section. (2) 50p2 (5) 34p1 (5) 68p2 (2) 39p2 (2) 32 Medium Lipid 11p1 (2) 30p4 (5) 2p1 (5) 3p0.1 (2) 27p3 (6) 46 Hydrophilic metabolites 67p1 (2) 20p4 (5) 61p3 (5) 29p2 (2) 37p4 (6) 23 Total 77p2 (2) 50p2 (5) 63p2 (5) 32p2 (2) 64p2 (6) 68 * From data in [14] .
Table 2 Distribution of intracellular lipid products derived from incubation of HeLa D cells with exogenous tritiated lyso-alkyl-GlcN-PI or lyso-PI for 24 h
Washed cells were treated with PI-PLC for 1 h at 4 mC and intracellular lipids were isolated as in Table 1 . Amounts were calculated as percentages of the total labelled lipid added to a tissueculture dish. Values are meanspS.E.M. for the number of experiments indicated in parentheses. (Figure 1 ). PI-PLC treatment of the extracted lipids also revealed that a small amount of the exogenous lyso-alkyl-GlcN-[$H]PI was incorporated and modified to more polar lipids. We sometimes observed a minor PI-PLC-resistant lipid product which migrated on TLC to a position slightly more polar than that of lyso-alkyl-GlcN-[$H]PI and less polar than that of H6 (Figure 1, lanes 3 and 4) . To examine whether this was a mannosylated GPI intermediate downstream from GlcN(acyl)PI, we treated the PI-PLC-resistant lipids with Jack-bean α-mannosidase, an enzyme that cleaves unsubstituted mannose residue(s) from GPIs and subsequently renders the cleaved GPIs less polar. However, treatment with α-mannosidase did not result in a clear shift in the mobility of the observed lipid (results not shown), and thus its nature remains unclear.
Distribution of radiolabel (%) Exogenous lipid … lyso-alkyl-GlcN-PI lyso-PI
To assess the extent to which lyso-alkyl-GlcN-[$H]PI and GlcN-[$H]PI obtained after the 24 h incubation were exposed on the cell surface, lipids extracted from intact cells treated with or 
Scheme 2 One-compartment model
Inositol (A) is incorporated into PI (B ) with rate constant k 1 . PI is modified into GlcN(acyl)PI (C ; rate constant k 2 ) and GlcN(acyl)PI is converted into a mannosylated GPI (D ; rate constant k 3 ). The rate constants for degradation or other metabolism of each species are k a -k d . [14] , even though GlcN(acyl)PI was effectively labelled and accumulated in a relatively large amount. To investigate the difficulty in labelling mannosylated GPIs in these cells, we asked whether the large amount of GlcN(acyl) [ [22] .
exogenous lipid, and this conclusion was supported by the fact that we did not observe formation of [$H]PI during incubation with lyso-alkyl-GlcN-[$H]PI. [$H]PI is by far the most abundant lipid synthesized from [$H]inositol.
GlcN(acyl)[ 3 H]PI accumulates in a relatively inert compartment in HeLa D cells
No detectable downstream mannosylated GPI intermediates were produced by labelling HeLa D cells with exogenous lysoalkyl-GlcN-[$H]PI (as noted above with Figure 1) or with [$H]PI or lyso-[$H]PI
To examine this question in a more quantitative manner, we considered the one-compartment model in Scheme 2. In this 14 
C ratios of inositol phospholipids and GPIs in HeLa D cells after sequential incubation with [ 14 C]inositol for 60 h followed by [ 3 H]inositol for 6 or 12 h
The cells were treated with PI-PLC for 1 h at 37 mC after both the first and the second incubations. Cellular lipids were extracted after the second incubation and analysed by TLC, and bands of radiolabelled lipids localized by fluorography were scraped from TLC plates and scintillation counted (see the Experimental section). GPIs are arranged in their order in the proposed biosynthetic pathway, and 3 H/ 14 C ratio data are the means (pS.E.M.) from four measurements (two independent experiments in duplicate). Values for GPI anchors were obtained from GPI-anchored proteins released by the second PI-PLC treatment, precipitated with trichloroacetic acid and purified by SDS/PAGE. Ratios were determined by dual-channel scintillation counting of gel slices and are the meanspS.E.M. of two-four experiments. Absolute recoveries of 14 TLC analysis of the labelled cellular lipids obtained from the double-labelling experiments resolved a number of species in addition to PI and GlcN(acyl)PI, and each species was assigned by its mobility relative to standards. The silica band corresponding to each lipid was then scraped from the TLC plate, and its $H\"%C ratio was determined by dual-channel scintillation counting. The $H\"%C ratios of all the resolved lipids are shown in Table 3 . To compare results obtained under different conditions, the observed $H\"%C ratio for each species was normalized to the $H\"%C ratio for PI in each experiment. As predicted by the one-compartment model, the normalized ratio of 1.0 for the first intermediate PI was the highest normalized ratio among all labelled lipids. Extension of this model to the additional components of the GPI pathway in Table 3 Table 3 revealed rapid turnovers and rates of approach to the steady state for these lipids. Furthermore, a lower $H\"%C ratio for GlcN(acyl)PI (0.18-0.24) than for PI initially is consistent with the prediction of the one-compartment model. However, Table 3 revealed a discordance relative to the ratios of the mannosylated GPIs H6, H7 and H8 that are downstream from GlcN(acyl)PI. Following 12 h labelling with [$H]inositol, the ratios of $H\"%C in H6 (0.46), H7 (0.7) and H8 (0.43) were much higher than that of the upstream GlcN(acyl)PI (0.24). The low ratio for GlcN(acyl)PI indicated that this lipid is distributed between more than one pool, thus violating the one-compartment model, and demonstrated that some GlcN(acyl)PI has a distinctly slower turnover rate than H6, H7 or H8. Similar conclusions were evident from the relative ratios in the 6 h labelling with [$H]inositol in Table 3 .
We also measured the $H\"%C ratio of GPI-anchored proteins released by the second cell-surface PI-PLC treatment, since these released proteins consisted both of ["%C]GPI-anchored proteins that were initially immature during the first PI-PLC treatment and freshly synthesized [$H]\["%C]GPI-anchored proteins. The GPI-anchored proteins were precipitated from PI-PLC-treated medium and analysed by SDS\PAGE (Figure 3) . Lanes containing GPI-anchored proteins were sliced at 5 mm intervals and scintillation counted to determine the $H\"%C ratio of the eluted radioactivity. Ratios of $H\"%C were roughly constant for two major inositol-labelled bands and corresponded to 0.45 for the 12 h labelling and 0.26 for the 6 h labelling. These ratios also were higher than those for GlcN(acyl)PI, indicating that even GPI anchors, the final product of the GPI pathway, have faster turnover rates than GlcN(acyl)PI. Table 3 and the Experimental section. The medium taken from the second PI-PLC treatment was treated with trichloroacetic acid, and the precipitate was analysed by SDS/PAGE as outlined in the Experimental section. Individual gel lanes were sliced, and 3 H and 14 C c.p.m. were determined by scintillation counting.
DISCUSSION
In these experiments, we observed cellular uptake of exogenous lyso-alkyl-GlcN-PI by HeLa D cells. This uptake was improved by adding EGTA to reduce lipid degradation by extracellular Ca# + -dependent phospholipase(s). Instead of simply remaining on the cell surface, the incorporated lipid entered the cells, as evidenced by its intracellular metabolism (e.g. inositol acylation) and its partial resistance to a membrane-impermeable probe (PI-PLC). This study demonstrates for the first time that an exogenous GPI can reach a GPI biosynthetic compartment in cultured cells and proceed at least part of the way along the pathway, as shown by its metabolism into GlcN(acyl)PI. This processing of exogenous lyso-alkyl-GlcN-PI supports the potential use of exogenous GPIs as therapeutic agents for PNH.
Exogenous lyso-alkyl-GlcN-PI as well as two other exogenous lipids (PI and lyso-PI) can be modified into GlcN(acyl)PI, and this GPI intermediate also accumulated to high levels in HeLa D cells after [$H]inositol metabolic labelling [15] .
The uptake of exogenous lyso-alkyl-GlcN-[$H]PI and exogenous lyso-[$H]PI in
HeLa D cells shared some similarities : (i) the extents of their uptake were increased by EGTA, (ii) they were translocated inside the cell and (iii) they were susceptible to sn-2 acylation. [22] . While these cells accumulated unusual amounts of GlcN(acyl)PI (10( molecules\cell determined by metabolic labelling with [$H]inositol [15] ), mannosylated GPIs were observed in amounts typical of other cell lines. Therefore, the metabolism of GlcN(acyl)PI by the first mannosyl transferase in HeLa D cells was not blocked, but the GlcN(acyl)PI mannosyl transferase activity in these cells appeared not to exceed that in other cells despite the high level of GlcN(acyl)PI.
Current study of lyso-alkyl-GlcN-PI as a precursor is limited by the small amount of exogenous lipid radiolabel available and particularly by its low specific radioactivity. At a specific radioactivity of $ 1 Ci\mmol, the exogenous labelled lipids introduced in the experiments here (0.15-0. The mannosylation efficiency, defined as the ratio of H6jH7jH8 to GlcN(acyl)PI, was only 0.097p0.004 for the "%C-labelled lipids in Table 3 . A similar mannosylation efficiency for GlcN(acyl)[$H]PI produced from 0.2 µCi of exogenous lysoalkyl-GlcN-[$H]PI would result in less than 1000 c.p.m. of H6, H7 and H8 in total, an amount barely detectable with our methods. One possible explanation for the failure to see increased mannosylation despite the high level of GlcN(acyl)PI in HeLa D cells is that the first mannosyl transferase is saturated at the low level of GlcN(acyl)PI typical of most cells. This would result in a constant rate of mannosylation regardless of the cellular GlcN(acyl)PI concentration. An alternative possible explanation is that GlcN(acyl)PI in HeLa D cells largely accumulates in an inactive compartment devoid of mannosyl transferase where an increased concentration of GlcN(acyl)PI would have no effect on the rate of mannosylation.
To investigate these two explanations for the poor efficiency of GlcN(acyl)PI mannosylation, we examined whether GlcN(acyl)PI synthesized de no o from radiolabelled inositol was in a single pool or compartment. We tested this single-compartment model with an experiment in which HeLa D cells were first labelled with ["%C]inositol for 60 h and then labelled with [$H]inositol for 6 or 12 h. Ratios of $H\"%C incorporation provided information about several lipid species (Table 3) . The one-compartment model in Scheme 2 predicts that the $H\"%C ratio in mannosylated GPIs will be lower than or equal to that in upstream GlcN(acyl)PI. Our data lead us to reject a onecompartment hypothesis for GlcN(acyl)PI, because the $H\"%C ratios in mannosylated GPIs (H6, H7 and H8) were higher than that of GlcN(acyl)PI. The $H\"%C ratio in the last component of the biosynthetic pathway, GPI-anchored proteins, is clearly of interest because it sets a lower limit for the ratio of any intermediate that is confined to only a single biosynthetic compartment. In an effort to improve the accuracy of the estimate of this ratio, HeLa D cells were treated with PI-PLC at 37 mC after the initial 60 h labelling with ["%C]inositol to clear as much pre-existing ["%C]GPI-anchored proteins as possible. At 4 mC, cell-surface GPI-anchored proteins were cleaved more slowly than cell-surface free inositol phospholipids by PI-PLC treatment, whereas both proteins and lipids were readily removed by PI-PLC treatment at 37 mC. Clearing from the cell surface was relatively effective, as a second treatment with PI-PLC 30 min later released only about 15 % of the "%C-labelled proteins cleaved in the initial PI-PLC treatment (A. Wongkajornsilp and T. L. Rosenberry, unpublished work). However, some intracellular "%C-labelled GPI-anchored proteins still remained following this procedure. These proteins along with GPI-anchored proteins newly synthesized from the free GPI pools continued to move to the cell surface during the subsequent labelling with [$H]inositol for an additional 6-12 h, and they lowered the $H\"%C ratio of the newly synthesized proteins released by another PI-PLC treatment. Nevertheless, the $H\"%C ratio for the released GPI-anchored proteins exceeded those for GlcN(acyl)PI at both the 6 and 12 h time points. The $H\"%C ratio obtained from 12 h labelling (0.45) is higher and more accurate than that from 6 h labelling (0.26) since the pre-existing pool of "%C-labelled GPI-anchored proteins make a smaller contribution after 12 h. We conclude that [$H]inositol was effectively incorporated into mannosylated GPIs and GPI anchors largely by bypassing the pool of accumulated GlcN(acyl)PI.
We suggest a two-compartment model to explain the heterogeneous GlcN(acyl)PI pool. The two separate compartments are defined on the basis of the turnover of GlcN(acyl)PI. The relatively low $H\"%C ratio in GlcN(acyl)PI indicated that freshly synthesized GlcN(acyl)[$H]PI was more readily used for further biosynthesis of mannosylated GPIs than was the preexisting GlcN(acyl)["%C]PI. Therefore, freshly synthesized GlcN(acyl)[$H]PI and pre-existing GlcN(acyl)["%C]PI are not homogeneously mixed. Most pre-existing GlcN(acyl)["%C]PI must accumulate in a separate compartment in which it is not actively utilized for further GPI biosynthesis. Some GlcN(acyl)PI in HeLa D cells is deposited in the plasma-membrane fraction (D. Sevlever, unpublished work) and the majority (70 %) is present in Triton-insoluble microdomains [23] . These pools partially overlap, and one or both may correspond to GlcN(acyl)PI that is physically isolated from the corresponding first mannosyl transferase in the endoplasmic reticulum. The indication that most GlcN(acyl)PI resides in a compartment in which it undergoes mannosylation slowly if at all may be relevant to the success of exogenous lipids like lyso-alkyl-GlcN-PI as GPI anchor precursors. If GlcN(acyl)PI generated from these exogenous lipids fails to enter compartment(s) active in GPI mannosylation and remains confined to an inert compartment, the exogenous lipids will be ineffective precursors. Further experiments with larger quantities and higher specific activities of lyso-alkyl-GlcN-[$H]PI will be necessary to resolve this point for Hela D cells as well as for other cells. Our results suggest that it may be difficult to utilize lyso-alkyl-GlcN-PI as an exogenous precursor to bypass the defect in PNH cells. However, the strategy of using exogenous glycolipids to correct this defect remains important and largely ignored. The possibility remains that other exogenous precursors, like a lyso-alkyl mannosylated (GlcN)PI, may be converted more efficiently into intermediates that do proceed through the GPI pathway. Table 3 reveals that other GPI intermediates also distribute at least partially in an inert compartment. The lowest observed $H\"%C ratio belonged to lipid b, a lipid with a mobility between PI and GlcN(acyl)PI on TLC. Lipid b was previously implicated as a degradation product of GlcN(acyl)PI [15] , and its very low $H\"%C ratio is consistent with its formation in the inert compartment which contains GlcN(acyl)PI. The $H\"%C ratio for GlcN-PI at 12 h of [$H]inositol labelling (0.25) appeared to be as low as that of GlcN(acyl)PI. The GlcN-PI band on TLC was very close to the PI band and hence any contamination with the PI band during scraping could make the observed $H\"%C ratio for GlcN-PI artificially high, perhaps accounting for a higher ratio (0.64) at 6 h of [$H]inositol labelling. Nevertheless, these ratios suggest that GlcN(acyl)PI may be converted from GlcN-PI in the inert compartment, in parallel with the same conversion in the more active GPI biosynthetic compartment. The $H\"%C ratio for H7 was higher than that for H6, particularly with the 12 h [$H]inositol labelling, indicating that freshly synthesized H6 was more readily used for further biosynthesis than pre-existing H6. There is evidence for the distribution of H6 in multiple compartments, as H6, H7 and H8 have been reported in the plasma membranes of several cell lines, including K562, MadinDarby canine kidney, HeLa and lymphoma (EL-4) [24] [25] [26] [27] . Furthermore, inert compartments may exist even within the endoplasmic reticulum, as some steps of the mammalian GPI anchor pathway have been suggested to occur in different endoplasmic reticulum regions [23, 28] and in endoplasmic reticulum-associated membranes [29] . The relatively high $H\"%C ratio for H7 suggests that H7 is rapidly metabolized, possibly into GPI anchors on proteins. Rapid transfer of H7 to protein acceptors would be compatible with the observation that the predominant structure in GPI anchors corresponds to that of H7 (e.g. rat brain Thy-1 [30] , human erythrocyte acetylcholinesterase [31] , hamster brain scrapie prion protein [32] , human placental alkaline phosphatase [33] and CD52 [34] ).
